El hepatocarcinoma

Authors

  • M. Iñarrairaegui

DOI:

https://doi.org/10.23938/ASSN.0275

Downloads

Download data is not yet available.

References

1. FERLAY J, SOERJOMATARAM I, DIKSHIT R, ESER S, MATHERS C, REBELO M et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386.

https://doi.org/10.1002/ijc.29210

2. VARELA M, REIG M, DE LA MATA M, MATILLA A, BUSTAMANTE J, PASCUAL S et al. Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros. Med Clin 2010; 134: 569-576.

https://doi.org/10.1016/j.medcli.2009.10.042

3. ELIZALDE APESTEGUI IR, SALDAÑA DUEÑAS C, GOÑI ESARTE S, PRIETO MARTINEZ C, SANGRO GOMEZ-ACEBO B, ZOZAYA URMENETA JM. El hepatocarcinoma en la Comunidad Foral de Navarra: estudio de características y evolución en la práctica clínica habitual. An Sist Sanit Navar 2016; 39:

4. BRUIX J, SHERMAN M. AASLD practice guideline. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.

https://doi.org/10.1002/hep.24199

5. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943.

https://doi.org/10.1016/j.jhep.2011.12.001

6. D'AVOLA D, IÑARRAIRAEGUI M, PARDO F, ROTELLAR F, MARTI P, BILBAO JI et al. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages. Ann Surg Oncol 2011; 18: 1964-1971.

https://doi.org/10.1245/s10434-011-1551-4

Published

2016-08-31

How to Cite

1.
Iñarrairaegui M. El hepatocarcinoma. An Sist Sanit Navar [Internet]. 2016 Aug. 31 [cited 2025 Dec. 20];39(2):179-80. Available from: https://recyt.fecyt.es/index.php/ASSN/article/view/51998

Issue

Section

Editorial

Most read articles by the same author(s)